Led by researchers from California-based Stanford University School of Medicine, the study used biosensors to record more than 250,000 daily measurements for 43 participants. By combining biosensor information with other medical measurements, they observed that wearable devices were able to identify early signs of Lyme disease and to identify physiological differences between insulin-sensitive and insulin-resistant individuals.
The researchers concluded, “These results indicate that portable biosensors provide useful information for monitoring personal activities and physiology.”
More articles on health IT:
ONC names winners of 2 consumer, provider app challenges
Jonathan Bush: Legacy software should ‘hear their death knell’
Study: Can mental health apps reduce anxiety, depression symptoms?
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
